Ignite Creation Date:
2024-05-06 @ 3:44 PM
Last Modification Date:
2024-10-26 @ 1:56 PM
Study NCT ID:
NCT04743765
Status:
RECRUITING
Last Update Posted:
2024-06-26
First Post:
2021-02-03
Brief Title:
HIP Fracture Accelerated Surgical TreaTment And Care tracK 2 Trial
Sponsor:
Population Health Research Institute
Organization:
Population Health Research Institute
Study Overview
Official Title:
HIP Fracture Accelerated Surgical TreaTment And Care tracK 2 HIP ATTACK-2 Trial
Status:
RECRUITING
Status Verified Date:
2024-10
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
HIP ATTACK-2
Brief Summary:
The HIP ATTACK-2 trial is a multicentre international parallel group randomized controlled trial to determine whether accelerated surgery for hip fracture in patients with acute myocardial injury is superior to standard care in reducing death at 90 days after randomization The trial will also assess secondary outcomes at 90 days after randomization inability to independently walk 3 metres time to first mobilization first standing and first full weight bear composite and individual assessment of major complications eg mortality non-fatal myocardial infarction acute congestive heart failure and stroke delirium length of stay pain and quality of life
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None